Skip to main content
Premium Trial:

Request an Annual Quote

ATCC to Use NJ Hospital Samples in Pancreatic Cancer Biomarker Hunt

NEW YORK (GenomeWeb News) - American Type Culture Collection will use certain genomic technologies to study pancreatic tissue samples collected at a New Jersey Hospital for biomolecules that can be used to help detect, monitor, and potentially treat pancreatic cancer, ATCC said Thursday.
 
ATCC’s platform consists of integrated genomics, proteomics, and bioinformatics technologies and “has already demonstrated effectiveness in uncovering novel biomarkers for type 2 diabetes,” the company said.
 
Under the agreement, ATCC will use its biomarker-discovery platform on pancreatic cancer samples from The Valley Hospital of Ridgewood, and the hospital will provide blood and clinical advice on validation and application of biomarker discoveries stemming from the collaboration.
 
ATCC scientists will also use the company’s Cell Biology Collection to test for the presence or absence of “various biomarkers across a wide range of cell lines.” ATCC and The Valley Hospital will form a Joint Research and Development Committee to address the objectives and progress of the research initiatives.
 
Financial terms of the agreement were not released.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.